Zhejiang, China

Renbao He


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Renbao He: Innovator in Biocatalysis and Pharmaceutical Intermediates

Introduction

Renbao He is a notable inventor based in Zhejiang, China, recognized for his contributions to the field of biocatalysis and pharmaceutical intermediates. With a total of three patents to his name, he has made significant advancements in the synthesis of important chemical compounds.

Latest Patents

One of Renbao He's latest patents is titled "Transaminase mutant and application thereof in preparation of sitagliptin intermediates." This invention discloses a transaminase mutant achieved through specific amino acid substitutions, which serves as a biocatalyst for preparing sitagliptin intermediates. The method boasts a total yield of approximately 82%, with an enantiomeric excess value of 99%. Another significant patent is the "Method for synthesizing 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid and intermediates thereof," which outlines a systematic approach to synthesize this compound.

Career Highlights

Renbao He has worked with reputable organizations, including Zhejiang Yongtai Technology Co., Ltd. and Zhejiang University. His experience in these institutions has contributed to his expertise in the field of chemical synthesis and biocatalysis.

Collaborations

Throughout his career, Renbao He has collaborated with notable colleagues such as Hongming Shao and Yizhong Jin. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Renbao He stands out as an innovative inventor whose work in biocatalysis and pharmaceutical intermediates has the potential to impact the industry significantly. His patents reflect a commitment to advancing chemical synthesis methods, showcasing his expertise and dedication to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…